Precision BioSciences (DTIL) draws 1.1M-share Weinstein stake

Rhea-AI Filing Summary

PRECISION BIOSCIENCES INC (DTIL) received an amended Schedule 13G/A reporting the holdings of Benjamin Weinstein in its common stock.

Weinstein reports 1,105,720 shares beneficially owned, including 203,500 shares issuable upon exercise of warrants, representing 4.01% of the common stock. The percentage is based on 27,601,554 shares outstanding as of August 3, 2026. He reports sole and shared voting and dispositive power over the same 1,105,720 shares and confirms ownership of 5% or less of the class.

Key Figures

Shares beneficially owned: 1,105,720 shares Warrant shares included: 203,500 shares Shares outstanding: 27,601,554 shares +3 more

6 metrics

Shares beneficially owned 1,105,720 shares Benjamin Weinstein’s reported beneficial ownership of DTIL common stock

Warrant shares included 203,500 shares Common shares issuable upon exercise of warrants included in beneficial ownership

Shares outstanding 27,601,554 shares DTIL common stock outstanding as of August 3, 2026

Percent of class owned 4.01% Benjamin Weinstein’s beneficial ownership percentage of DTIL common stock

Sole voting power 1,105,720 shares Shares over which Weinstein has sole power to vote or direct the vote

Sole dispositive power 1,105,720 shares Shares over which Weinstein has sole power to dispose or direct disposition

Key Terms

beneficially owned, Sole Voting Power, dispositive power, Schedule 13G/A

4 terms

beneficially owned financial

"Amount beneficially owned: 1,105,720 Includes 203,500 shares of Common Stock issuable"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

Sole Voting Power financial

"5 | Sole Voting Power 1,105,720.00 6 | Shared Voting Power"

Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.

dispositive power financial

"Sole Dispositive Power 1,105,720.00 8 | Shared Dispositive Power 1,105,720.00"

Dispositive power is the authority to decide the final outcome of an asset, legal claim, contract, or corporate action — in effect the power to dispose of or resolve something. For investors it matters because whoever holds that authority can determine who gets paid, who controls an asset or vote, and how risks and returns are allocated; think of it like holding the key that lets you lock in the winner or loser in a deal.

Schedule 13G/A regulatory

""form_type": "SCHEDULE 13G/A""

A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.

FAQ

What percentage of PRECISION BIOSCIENCES INC (DTIL) does Benjamin Weinstein report owning in this Schedule 13G/A?

Benjamin Weinstein reports beneficial ownership of 4.01% of PRECISION BIOSCIENCES INC (DTIL) common stock, based on 27,601,554 shares outstanding as of August 3, 2026, as referenced in the company’s Quarterly Report for the quarter ended June 30, 2026.

How many DTIL shares does Benjamin Weinstein beneficially own according to this filing?

Benjamin Weinstein reports beneficial ownership of 1,105,720 shares of PRECISION BIOSCIENCES INC (DTIL) common stock, which includes 203,500 shares issuable upon exercise of warrants. This total forms the basis for his reported 4.01% ownership of the class.

What portion of Benjamin Weinstein’s DTIL position comes from warrants?

Out of Benjamin Weinstein’s reported 1,105,720 beneficially owned DTIL shares, 203,500 shares are issuable upon exercise of warrants. The remainder consists of currently outstanding common shares, collectively representing 4.01% of the company’s common stock.

What share count for DTIL is used to calculate Benjamin Weinstein’s ownership percentage?

The reported 4.01% ownership is calculated using 27,601,554 shares of common stock outstanding as of August 3, 2026, as reported by PRECISION BIOSCIENCES INC in its Quarterly Report on Form 10-Q for the period ended June 30, 2026.

Does this Schedule 13G/A indicate that Benjamin Weinstein owns 5% or more of DTIL?

No. The filing states that Benjamin Weinstein’s beneficial ownership of PRECISION BIOSCIENCES INC (DTIL) common stock is 4.01%, and Item 5 explicitly identifies this as ownership of 5 percent or less of the class.

What voting and dispositive powers over DTIL shares does Benjamin Weinstein report?

Benjamin Weinstein reports 1,105,720 shares for each of sole voting power, shared voting power, sole dispositive power, and shared dispositive power with respect to PRECISION BIOSCIENCES INC (DTIL) common stock, matching his total beneficially owned position of 1,105,720 shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/24/2026 - 03:13 PM Accepted by SEC EDGAR 08/24/2026 - 03:13 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

PRECISION BIOSCIENCES INC

(Name of Issuer)

Common Stock, par value $0.000005 per share

(Title of Class of Securities)

74019P207

(CUSIP Number)

08/21/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 74019P207

1

Names of Reporting Persons

Weinstein Benjamin

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 1,105,720.00
6	Shared Voting Power 1,105,720.00
7	Sole Dispositive Power 1,105,720.00
8	Shared Dispositive Power 1,105,720.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,105,720.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

4.0 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: PRECISION BIOSCIENCES INC
(b)	Address of issuer's principal executive offices: 302 EAST PETTIGREW STREET, 302 EAST PETTIGREW STREET, DURHAM, NORTH CAROLINA, 27701
Item 2.
(a)	Name of person filing: Benjamin Weinstein
(b)	Address or principal business office or, if none, residence: 15301 Dallas Parkway Suite 800 Dallas, TX, 75001
(c)	Citizenship: United States
(d)	Title of class of securities: Common Stock, par value $0.000005 per share
(e)	CUSIP No.: 74019P207
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 1,105,720 Includes 203,500 shares of Common Stock issuable upon exercise of Warrants. The percentage set forth in this Schedule 13G is calculated based upon an aggregate of 27,601,554 shares of Common Stock outstanding as of August 3, 2026, as reported in the Company's Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2026.
(b)	Percent of class: 4.01%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 1,105,720
	(ii) Shared power to vote or to direct the vote: 1,105,720
	(iii) Sole power to dispose or to direct the disposition of: 1,105,720
	(iv) Shared power to dispose or to direct the disposition of: 1,105,720
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Weinstein Benjamin

Signature:	Benjamin Weinstein
Name/Title:	Individual
Date:	08/24/2026